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The  principal  obstacle  to  successful  clinical  transplantation  of  a  human 
organ, immunological rejection, seems to be  a  result of inadequacies in two 
areas: (a)  the inability to induce tolerance to tissue antigens; and (b)  the in- 
ability  of  present  donor-recipient  matching  schemes  to  differentiate major 
histocompatibility antigens from other cell-associated antigens. The importance 
of surmounting the latter stems from the fact that the immune activity against 
nonmajor histocompatibility antigens is  relatively easily controlled  via  im- 
munosuppressive  therapy,  whereas,  the  immune  activity  incited  by  major 
histocompatibility antigens primarily those encoded by the FOUR end (1,  2) 
of the HL-A locus (tt-2K region of the mouse [3]) is very difficult to control. 
Presently, two methods are used in assessing the relationship of histocompat- 
ibility antigens of donors and recipients for organ transplantation; tissue typing 
(serology) and the mixed leukocyte reaction  (MLR) assays. A  third, the re- 
lease of 51Cr from target cells by killer cells produced in one-way MLR, termed 
"cell-mediated lympholysis or CML" (4), is presently under investigation (5). 
Statistically, MLR testing and serotyping correlate to homograft reactivity 
(6). However, numerous anomalies of MLR reactivity and serotyping result 
in a state in which neither technique accurately predicts the success or failure 
of  graft  survival  before  transplantation. Thus,  successful  transplantation  of 
kidney grafts has  been  frequently achieved between familial-unrelated sero- 
logically nonidentical individuals (7-9);  and transplantation of bone marrow 
as a  therapeutic protocol for leukemia between  serologically as well  as  MLR 
identical siblings has in many cases been unsuccessful because of a fatal graft 
vs.  host reaction (10-13).  Of these two techniques, evidence is, however, ac- 
cumulating which suggests that  the  MLR will be of more value  (14,  15)  in 
predicting the clinical outcome of organ transplants. 
The major disadvantages of the MLR are that it is unclear as to the nature 
of the antigens that induce stimulation. In the mouse model nonmajor histo- 
compatibility antigens can cause stimulation (16-18),  in some cases equal in 
magnitude to  major  histocompatibility induced  stimulation  (16-18).  There- 
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fore, to increase the value of the MLR for tissue matching, it seems imperative 
to define the antigens that induce MLR activity and to be able to differentiate 
major histocompatibility  antigens from other cell-associated antigens.  It may 
also be of importance  to differentiate  these other nonmajor alloantigens  from 
each other. 
Because  of  the  multitude  of  mouse  strains  which  have  been  genetically 
defined,  plus  the  apparent homology of the major histocompatibility  locus of 
man (HL-A) and mouse (//-2)  (19), this species should be the most valuable in 
establishing  assays  which measure  antigens  that  are  of major  importance  in 
transplantation.  Utilizing  a  dual  MLR  system,  one  in  a  chemically  defined 
protein-free  medium  (17)  and  the other in  a  mouse serum supplemented  me- 
dium (20,  21),  stimulation by alloantigens  associated with  the H-2 region has 
been differentiated  from stimulation by two non-//'-2 alloantigens  (18).  More- 
over, stimulation  due  to these two non-//-2 alloantigens,  the theta antigen  of 
thymus or thymus-derived cells (22)  and the product of the M-locus (16), can 
be distinguished from each other (18,  22). 
The  results  of the present  report  are  an  extension  of our investigations  on 
the definition of nonmajor histocompatibility  antigens which induce MLR  re- 
activity.  Specifically, the  results  indicate  that  the  stimulatory product of the 
M-locus is not present  on thymus cells: The significance of this finding is dis- 
cussed in  relationship  to  the  CML  assay  in  which phytohemagglutinin-stim- 
ulated  cells  (T cells)  are the ~lCr-labeled  target cells. 
Materials and Methods 
Mice.--Inbred strains used in this study and raised in this laboratory are BALB/cHeAu, 
C3H/HeAu, and DBA/2J. Both male and female mice were used, ranging in age from 5 to 
7 wk. Within any one experiment, the sex and age of the animals were the same. 
MLR Conditions.--Preparation of cells, X irradiation  of the stimulating  cell populations, 
culture  conditions, and  determination  of [3H]thymidine incorporation  are detailed  in other 
reports  (17, 21). The protocol for preparation  of mouse serum is also detailed elsewhere (20). 
Spleen cells, thymus cells, and sera were always pools of three  or more mice. The culture 
medium  (obtained from Altick Assoc., Madison, Wis.) was supplemented  to contain  0.5o-/0 
autologous (to the responding strain) serum. 
The results presented are representative  of those obtained in many experiments. Counts 
per minute are the means of triplicate cultures. Stimulation indices are the ratios of [3H]TdR 
incorporated in allogeneic reactions to that incorporated in syngeneic reactions. 
Sufficient inactivation  of the stimulating  cells by X irradiation  was assessed in each ex- 
periment  by culturing together  X-irradiated  cells from each of two allogeneic populations. 
[3H]TdR incorporation by these X-irradiated  controls was less than 10~o of the syngeneic 
controls. This was considered adequate inactivation. 
RESULTS 
Table  I  presents  results  which  confirm the  reported  reactivity  of BALB/c 
spleen  cells  against  DBA/2  (M-locus  products)  and  C3H  (//-2  alloantigens) 
spleen  cells  (16-18).  BALB/c thymus cells were  also  found to be  stimulated 
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TABLE  I 
MLR Stimulatory Capacity of H-2 and Non-H-2 Alloantigens Presenl on Spleen and 
Thymus Calls 
Sources of  CPM 4- SE at:  Stimulation 
Stimulating  index at:  Reacting strain*  strain~  stimulating 
cells  72 h  98 h  72 h  98 h 
BALB/c spleen  BALB/c  Spleen  2,922  4- 92  2,801  4-  130  --  -- 
DBA/2  Spleen  27,471  4- 625  24,323  4- 2,850  9.4  8.7 
CsH  Spleen  37,345  4- 930  56,849  4-  1,380  12.8  20.3 
BALB/c  Thymus  2,439  4-  79  2,741  4-  170  --  -- 
DBA/2  Thymus  1,940  4-  36  2,823  4-  290  0.8  1.0 
C3H  Thymus  14,713  4-  990  22,690  4-  2,090  6.0  8.3 
C3H spleen  C3  H  Spleen  3,226  4-  4  3,949  4- 30  --  -- 
DBA/2  Spleen  64,619  4-  1,000  61,510  4- 3,200  19.7  15.5 
BALB/c thymus 
C3H  Thymus  4,550  4- 350  5,193  4- 338  --  -- 
DBA/2  Thymus  8,895  4- 380  12,908  4- 4  2.0  2.3 
BALB/c  Spleen  290  4-  40  230  4- 50  --  -- 
DBA/2  Spleen  17,365  4-  1,020  15,857  4-  500  60.0  68.9 
C$H  Spleen  3,160 4-  200  1,719  4-  i0  11.0  7.8 
* 1.5 X  106 cells. 
~: 2.5  X  106 cells. 
In  contrast  to  the  stimulatory properties of DBA/2  spleen  cells,  thymus 
cells of this strain did not stimulate BALB/c spleen cells.  BALB/c cells were, 
however, stimulated by thymus cells of the H-2 disparate strain, C3H. Although 
not to the extent of spleen cells,  DBA/2  thymus cells stimulated spleen cells 
of Call, an H-2 disparate strain. 
An  apparent  conflict between  the  present  and  our  previous  results  (18), 
which is related to the relative stimulation observed at 72 and 98 h of culture 
due to H-2 and M-locus differences, is because 2.5  X  106 stimulator cells were 
used in the present study while the optimal number of 2  X  106 were used in 
the previous experiments. This change was made so that the number of thymus 
and spleen cells used as antigen was constant. 
In  other  immune  systems,  evidence is  accumulating  which  indicates  that 
T  cells  have  a  suppressor  function  (23-27).  An  experiment,  therefore,  was 
designed to test whether the absence of stimulation by DBA/2  thymus cells 
was due to a  similar phenomenon. The results presented in Table II indicate 
that addition of 1 X  106 DBA/2 X-irradiated thymus cells neither stimulated 
nor inhibited  the activity of BALB/c cells against  2.5  X  106 DBA/2  spleen 
cells. Addition of 2 X  106 DBA/2 thymus cells were inhibitory, affecting both 
the syngeneic as well as the allogeneic reaction. This inhibition was, however, 
a  result  of suppression  by excessively high  numbers  of stimulating  cells,  as 
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TABLE II 
BALB/c  Spleen  Cdl  Reactivity Against  DBA/2  Spleen  Cells in the Presence and  Absence 
of Thymus Cells 
X-lrradlated spleen cells from:  No. of DBA/2 thymus cells  CPM at 72 h  Stimulation index 
BALB/c  none  2,971  -- 
DBA/2  none  16,140  5.4 
BALB/c  1 X 106  2,548  -- 
DBA/2  1 X 10  s  13,235  5.2 
BALB/c  2 X l0  s  1,309  -- 
DBA/2  2 X 106  4,833  3.7 
DISCUSSION 
Transplantation  has long offered the potential for correction of disease in 
which organ failure occurs. The major obstacle to successful organ transplanta- 
tion  is  rejection.  The  success  of  immunosuppressive  therapy  employed  to 
curtail  rejection is  related  to  the  strength  of antigen  disparity  (1-3).  Since 
the techniques employed to assess disparity do not accurately predict success 
or failure of graft survival before transplantation, either new techniques and/or 
modifications  of  existing  procedures  must  be  sought.  The  present  findings 
relate to one of the existing techniques, the MLR. 
It is generally considered that the MLR is primarily mediated by thymus- 
derived (T)  cells.  However, recent evidence employing chromosome markers 
indicates that  bone marrow  (B)  cells also proliferate in the presence of allo- 
geneic cells  (28).  In  experiments designed to identify the  MLR  stimulatory 
cells, conflicting findings have been reported. Lymphoid cells from neonatally 
thymectomized mice  and  rats  have  reduced  stimulatory  ability  suggesting 
that T lymphocytes may be required as stimulator cells (29), or that the stimu- 
latory cell is under thymic influence (30). In contrast, thoracic duct lympho- 
cytes  (TDL)  of nu/nu  mice  (>97%  B  cells)  were  as  stimulatory  as  TDL 
from nu/+  or +/+  littermates (80% T  cells)  (31); cells treated with anti- 
theta serum from spleens of thymectomized, X-irradiated  adult mice  recon- 
stituted with B  cells (T-cell depleted) stimulated  as well as spleen cells from 
untreated  animals  (32);  and  T-cell depleted  spleen  cells  (treated  with  anti- 
theta antiserum)  were better stimulators  than  "B-cell" depleted populations 
obtained by treating with  anti-Ly 4.2  antiserum  (33). The results  presented 
herein in which thymus cells were not as stimulatory as cells derived from the 
spleens of H-2 disparate strain combinations support the observations that the 
H-2 antigens of T  cells are not as stimulatory as those of B cells. Although the 
rationale for these  discrepancies  is  unclear,  different culture  conditions  and 
strains  of animals  (all  combinations were H-2  disparate)  were used by each 
investigator. 
In  the mouse,  alloantigens other than  those encoded by the H-2  complex 
are stimulatory in the MLR. For stimulation incited by theta alloantigens (22), 
thymus or T  cells,  but not B cells, would be expected to cause stimulation. In 1632  ROBERT E.  CLICK  BRIEF  DEFINITIVE  REPORT 
contrast,  as  shown  in  the  present  report,  stimulation  incited  by  disparity  at 
the M-locus is not a result of thymus alloantigens. Thymus cells were, however, 
responsive  to  M-locus  products.  It  is  not  known  whether  stimulation  is  a 
property of B  cells, T  cells, or some other cell type present in the spleen. 
The findings of others (31-33)  as well as those in this report in which thymus 
or T  cells were  found  to  either  lack or possess  diminished  MLR  stimulatory 
properties  raise  an  important  consideration  for  any  hypothesis  advanced  to 
explain  the  divergent  specificity of the  induction  (MLR  dependent)  and  the 
effector  (CML  which  is  dependent  on  HL-A  incompatibility)  phases  of  cell- 
mediated  immunity  (34-36).  That  is,  are  the  alloantigens  controlled  by  the 
various  MLR  loci  quantitatively  and  qualitatively  expressed  similarly  on 
both  the  cell  type(s)  that  stimulate  in  the  MLR  and  the  cell  type  (PHA- 
transformed T  cells)  employed as the target cell in CML? The unique  expres- 
sion of an M-locus allele on the cell type(s)  that induce MLR stimulation  and 
its  absence  from  thymus  cells  (which  can  explain  the  lack  of  CML  against 
this  antigen  [37])  make  it  imperative  to  answer  this  question  before  further 
hypotheses. 
SUMMARY 
The mixed leukocyte reaction stimulatory M-locus product of DBA/2 spleen 
cells was absent from thymus cells. The absence of stimulation was not a result 
of suppressor T  cells. These findings are discussed  in relation  to the  divergent 
specificity found for the inductive and effector phases of cell-mediated responses. 
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